Medicare AdvantageCoverageMedium impact
MA01.008d, Anesthesia Services for Epidural, Paravertebral Facet and Sacroiliac Joint Injections for Spinal Joint Management
Independence Blue Cross·Anesthesiology, Pain Management, Orthopedics·Pharmacy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
This policy, effective October 1, 2025, establishes Medicare Advantage coverage guidelines for anesthesia services used in epidural, paravertebral facet, and sacroiliac joint injections for spinal joint management. The policy was posted October 2, 2025 and is categorized as Pharmacy. Billing teams must review the full policy text to identify any new prior authorization requirements, covered anesthesia agents, dosing limits, or billing code restrictions that may affect claims processing.
Action Required
By October 15, 2025: Billing and clinical teams must obtain and review the complete policy text at the provided URL. Identify: (1) whether prior authorization is required for anesthesia services in these procedures, (2) which anesthesia agents/HCPCS codes are covered, (3) any documentation requirements. Update billing system rules, prior auth workflows, and provider encounter templates accordingly. For any claims submitted on or after 10/01/2025 for epidural, paravertebral facet, or sacroiliac joint injections, ensure anesthesia billing complies with MA01.008d requirements. Contact the payer directly if coverage details are unclear to prevent claim denials.